Evidence map›Paper›PMID 37726796›Full record

ArticleCritical care (London, England)2023

Non-ventilator-associated ICU-acquired pneumonia (NV-ICU-AP) in patients with acute exacerbation of COPD: From the French OUTCOMEREA cohort.

Louis-Marie Galerneau, Sébastien Bailly, Nicolas Terzi, Stéphane Ruckly, Maité Garrouste-Orgeas, Johanna Oziel, Vivien Hong Tuan Ha, Marc Gainnier, Shidasp Siami, Claire Dupuis and 12 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Critical care (London, England), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Unveiling the Prognostic Power of HRR in ICU-Admitted COPD Patients: A MIMIC-IV Database Study.International journal of chronic obstructive pulmonary disease · 2025
    Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 11 institutions in 1 country.

Louis-Marie GalerneauMedical Intensive Care Unit, University Hospital of Grenoble Alpes, 10217 38043, Grenoble, CS, France. lmgalerneau@chu-grenoble.fr.
Sébastien BaillyGrenoble Alpes University, INSERM 1300, HP2, Grenoble, France.
Nicolas TerziMedical Intensive Care Unit, University Hospital of Grenoble Alpes, 10217 38043, Grenoble, CS, France.
Stéphane RucklyDepartment of Biostatistics, Outcomerea, Paris, France.
Maité Garrouste-OrgeasMedical Unit, French and British Hospital Cognacq-Jay Fondation, Levallois-Perret, France.
Johanna OzielIntensive Care Unit, Avicenne Hospital, AP-HP, Paris, France.
Vivien Hong Tuan HaMedical Intensive Care Unit, Meaux Hospital, Meaux, France.
Marc GainnierMedical Intensive Care Unit, La Timone Hospital, Marseille, France.
Shidasp SiamiCritical Care Medicine Unit, Etampes-Dourdan Hospital, Etampes, France.
Claire DupuisMedical Intensive Care Unit, Gabriel Montpied University Hospital, Clermont-Ferrand, France.
Jean-Marie ForelMedical Intensive Care Unit, Nord University Hospital, Marseille, France.
Anaïs DartevelMedical Intensive Care Unit, University Hospital of Grenoble Alpes, 10217 38043, Grenoble, CS, France.
Julien DessajanMedical and Infectious Diseases Intensive Care Unit (MI2), Bichat Hospital, AP-HP, Paris, France.
Christophe AdriePolyvalent Intensive Care Unit, Delafontaine Hospital, Saint-Denis, France.
Dany Goldgran-ToledanoMedical Intensive Care Unit, Le Raincy-Montfermeil Hospital, Montfermeil, France.
Virginie LaurentIntensive Care Unit, André Mignot Hospital, Le Chesnay, France.
Laurent ArgaudMedical Intensive Care Unit, Edouard Herriot Hospital, Lyon Civil Hospices, Lyon, France.
Jean ReignierMedical Intensive Care Unit, Nantes University Hospital, Nantes, France.
Jean-Louis PepinGrenoble Alpes University, INSERM 1300, HP2, Grenoble, France.
Michael DarmonIntensive Care Unit, Saint-Louis Hospital, AP-HP, Paris, France.
Jean-François TimsitMedical and Infectious Diseases Intensive Care Unit (MI2), Bichat Hospital, AP-HP, Paris, France.
OUTCOME R. E. A. network
Assistance Publique – Hôpitaux de Paris · FRInserm · FRHospices Civils de Lyon · FRHôpital Nord · FRCentre Hospitalier Saint-Denis · FRInstitut Hospitalier Franco Britannique · FRNantes Université · FRGroupe Hospitalier Intercommunal Le Raincy Montfermeil · FRHôpital André Mignot · FRHôpital de la Timone · FRCentre Hospitalier Universitaire de Grenoble · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNon-ventilator-associated ICU-acquired pneumonia (NV-ICU-AP), a nosocomial pneumonia that is not related to invasive mechanical ventilation (IMV), has been less studied than ventilator-associated pneumonia, and never in the context of patients in an ICU for severe acute exacerbation of chronic obstructive pulmonary disease (AECOPD), a common cause of ICU admission. This study aimed to determine the factors associated with NV-ICU-AP occurrence and assess the association between NV-ICU-AP and the outcomes of these patients.

methodsData were extracted from the French ICU database, OutcomeRea™. Using survival analyses with competing risk management, we sought the factors associated with the occurrence of NV-ICU-AP. Then we assessed the association between NV-ICU-AP and mortality, intubation rates, and length of stay in the ICU.

resultsOf the 844 COPD exacerbations managed in ICUs without immediate IMV, NV-ICU-AP occurred in 42 patients (5%) with an incidence density of 10.8 per 1,000 patient-days. In multivariate analysis, prescription of antibiotics at ICU admission (sHR, 0.45 [0.23; 0.86], p = 0.02) and no decrease in consciousness (sHR, 0.35 [0.16; 0.76]; p < 0.01) were associated with a lower risk of NV-ICU-AP. After adjusting for confounders, NV-ICU-AP was associated with increased 28-day mortality (HR = 3.03 [1.36; 6.73]; p < 0.01), an increased risk of intubation (csHR, 5.00 [2.54; 9.85]; p < 0.01) and with a 10-day increase in ICU length of stay (p < 0.01).

conclusionWe found that NV-ICU-AP incidence reached 10.8/1000 patient-days and was associated with increased risks of intubation, 28-day mortality, and longer stay for patients admitted with AECOPD.

Indexed as

Healthcare-Associated PneumoniaPneumonia, Ventilator-AssociatedPulmonary Disease, Chronic ObstructiveHumansIntensive Care UnitsRespiration, ArtificialAcute exacerbation of chronic obstructive pulmonary diseaseIntensive care medicineNon-ventilator-associated ICU-acquired pneumoniaPrevalencePrognosis

Identifiers

PMID37726796
PMCPMC10508006
OpenAlexW4386846300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.